Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease

Atherosclerosis

Volumn 184, Issue 2, 2006, Pages 383-388

  Wang, Jun ^a   Sim, Ah Siew ^a   Wang, Xing Li ^b   Salonikas, Chris ^a   Naidoo, Daya ^a   Wilcken, David E L ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Asymmetric dimethylarginine; Coronary artery disease; Glomerular filtration rate; Homocysteine; Renal function; Smoking

Indexed keywords

ARGININE; HOMOCYSTEINE; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRITE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; URINARY EXCRETION;

ADULT; AGED; ARGININE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 30044441986     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.05.002     Document Type: Article

References (21)

1. J. Leiper, and P. Vallance Biological significance of endogenous methylarginines that inhibit nitric oxide synthases Cardiovasc Res 43 1999 542 548
2. P. Vallance, A. Leone, A. Calver, J. Collier, and S. Moncada Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure Lancet 339 1992 572 575
3. N.S. Anavekar, J.J. McMurray, and E.J. Velazquez Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 2004 1285 1295
4. A. Ito, P.S. Tsao, and S. Adimoolam Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase Circulation 99 1999 3092 3095
5. R.H. Boger, S.M. Bode-Boger, and P.S. Tsao An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes J Am Coll Cardiol 36 2000 2287 2295
6. A. Tawakol, T. Omland, M. Gerhard, J.T. Wu, and M.A. Creager Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans Circulation 95 1997 1119 1121
7. D.S. Celermajer, K.E. Sorensen, and V.M. Gooch Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 340 1992 1111 1115
8. M.C. Stuhlinger, R.K. Oka, and E.E. Graf Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine Circulation 108 2003 933 938
9. M.C. Stuhlinger, P.S. Tsao, and J.H. Her Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine Circulation 104 2001 2569 2575
10. T.M. Lu, Y.A. Ding, M.J. Charng, and S.J. Lin Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease Clin Cardiol 26 2003 458 464
11. P. McElduff, A. Dobson, R. Beaglehole, and R. Jackson Rapid reduction in coronary risk for those who quit cigarette smoking Aust NZ J Publ Health 22 1998 787 791
12. D.B. Cottrell, and C.S. Frings Evaluation of the Beckman Creatinine Analyzer 2 Clin Biochem 12 1979 159 161
13. T. Teerlink, R.J. Nijveldt, S. de Jong, and P.A. van Leeuwen Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography Anal Biochem 303 2002 131 137
14. D.L. Granger, R.R. Taintor, K.S. Boockvar, and J.B. Hibbs Jr. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction Meth. Enzymol 268 1996 142 151
15. L. Tarnow, P. Hovind, T. Teerlink, C.D. Stehouwer, and H.H. Parving Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes Diabetes Care 27 2004 765 769
16. P.M. Ridker, J.E. Buring, N.R. Cook, and N. Rifai C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women Circulation 107 2003 391 397
17. R.H. Boger The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor Cardiovasc Res 59 2003 824 833
18. T.F. Jonasson, T. Hedner, B. Hultberg, and H. Ohlin Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease Eur J Clin Invest 33 2003 543 549
19. R.H. Boger, S.M. Bode-Boger, and W. Thiele Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease J Am Coll Cardiol 32 1998 1336 1344
20. L. Raij, E.G. DeMaster, and E.A. Jaimes Cigarette smoke-induced endothelium dysfunction: role of superoxide anion J Hypertens 19 2001 891 897
21. H. Dayoub, V. Achan, and S. Adimoolam Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence Circulation 108 2003 3042 3047 (Epub 2003 November 3024)